Sadao Kamidono
- Molecular Biology top 5%
- Surgery top 2%
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Reproductive Medicine top 0.5%
- Co-authors
- Isao HaraSoichi ArakawaHideaki MiyakeMasato FujisawaKazuo GohjiHiroshi OkadaAkinobu GotohHiroshi Eto
- Topics
- Bladder and Urothelial Cancer Treatments (74 papers)Sperm and Testicular Function (49 papers)Testicular diseases and treatments (32 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Sadao Kamidono
367 papers receiving 6.3k citations
Peers
Comparison fields: 5 of 135
- Molecular Biology 2.2k
- Surgery 1.8k
- Oncology 1.4k
- Pulmonary and Respiratory Medicine 1.3k
- Reproductive Medicine 900
Countries citing papers authored by Sadao Kamidono
This map shows the geographic impact of Sadao Kamidono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sadao Kamidono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sadao Kamidono more than expected).
Fields of papers citing papers by Sadao Kamidono
This network shows the impact of papers produced by Sadao Kamidono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sadao Kamidono. The network helps show where Sadao Kamidono may publish in the future.
Co-authorship network of co-authors of Sadao Kamidono
This figure shows the co-authorship network connecting the top 25 collaborators of Sadao Kamidono. A scholar is included among the top collaborators of Sadao Kamidono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sadao Kamidono. Sadao Kamidono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 7 | |
| 3 | Double-blind, controlled study to evaluate safety and efficacy of doripenem and meropenem in patients with complicated urinary tract infection | 3 |
| 4 | Epidemiological Survey of Sexually Transmitted Diseases Prevalence in Japan : Sentinel Surveillance of STDs in 2000 | 4 |
| 5 | 37 | |
| 6 | 20 | |
| 7 | 71 | |
| 8 | 5 | |
| 9 | 2 | |
| 10 | 3 | |
| 11 | 1 | |
| 12 | Clinical study of tosufloxacin tosilate in the treatment of non-gonococcal urethritis | 5 |
| 13 | Comparative study on levofloxacin and ofloxacin in complicated urinary tract infections | 5 |
| 14 | Prostatic tissue levels of levofloxacin | 3 |
| 15 | Sclerosing lipogranuloma in the male genitalia: Two case reports | 3 |
| 16 | 2 | |
| 17 | 54 | |
| 18 | Clinical studies on CS-807 in the urological field | 5 |
| 19 | 0 | |
| 20 | Clinical Evaluation on Male Infertility | 2 |
About Sadao Kamidono
Sadao Kamidono is a scholar working on Urology, Reproductive Medicine and Surgery, having authored 385 papers that have together received 6.5k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (74 papers), Sperm and Testicular Function (49 papers) and Testicular diseases and treatments (32 papers). The work is most often cited by research in Urology (735 citations), Reproductive Medicine (900 citations) and Cancer Research (850 citations). Sadao Kamidono has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Isao Hara, Soichi Arakawa, Hideaki Miyake, Masato Fujisawa, Kazuo Gohji, Hiroshi Okada, Akinobu Gotoh, Hiroshi Eto, Shoji Hara and M. Fujisawa. Their work appears in journals such as Journal of Biological Chemistry, Cancer and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.